*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global biologics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 9% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.

Biologics, also known as biological drugs, are disease-modifying antirheumatic drugs (DMARDs) made from living organisms or consist of components of living organisms. They include a wide variety of products, such as vaccines, blood, blood components, cells, genes, tissues, allergens, and recombinant proteins, derived from humans, animals, birds, insects, plants, and microorganisms. These products control the production of vital proteins, modify human hormones and cells, while producing substances to activate and suppress the immune system. They also change the manner of operation of natural biologic intracellular and cellular actions. In recent years, biologics have gained immense traction as they are essentially utilized to treat various diseases and conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis and other autoimmune diseases.

Biologics Market Trends:

The global biologics market is primarily driven by the rising incidences and diagnosis of chronic diseases that have necessitated the availability of advanced diagnostics and treatment drugs. Biologics are genetically engineered to target a specific part of the immune system that fuels inflammation. Governments of different countries are also taking initiatives to promote the healthcare sector and ensure the availability of biologics with the onset of coronavirus disease (COVID-19). Furthermore, scientists and researchers are extensively investigating species and expression systems to enhance the productivity of biological products. Moreover, various pharmaceutical companies are undertaking research and development (R&D) activities to improve the efficacy of oral products for rheumatoid arthritis and Crohn’s diseases.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biologics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, source, product, disease and manufacturing.

Breakup by Source:

  • Microbial
  • Mammalian
  • Others
     

Breakup by Product:

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Antisense, RNAi and Molecular Therapy
  • Others
     

Breakup by Disease:

  • Oncology
  • Immunological Disorders
  • Cardiovascular Disorders
  • Hematological Disorders
  • Others
     

Breakup by Manufacturing:

  • Outsourced
  • In-House
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi.

Key Questions Answered in This Report:

  • How has the global biologics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global biologics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the source?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the manufacturing?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global biologics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Biologics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Source
    6.1    Microbial
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Mammalian
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Others
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Product
    7.1    Monoclonal Antibodies
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Vaccines
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Recombinant Proteins
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Antisense, RNAi and Molecular Therapy
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Disease
    8.1    Oncology
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Immunological Disorders
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Cardiovascular Disorders
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Hematological Disorders
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by Manufacturing
    9.1    Outsourced
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    In-House
        9.2.1 Market Trends
        9.2.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    AbbVie Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Amgen Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    AstraZeneca plc
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    F. Hoffmann-La Roche Ltd
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 SWOT Analysis
        15.3.5    GlaxoSmithKline plc
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Johnson & Johnson
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Merck KGaA
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Novartis AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Pfizer Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Sanofi
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Biologics Market: Major Drivers and Challenges
Figure 2: Global: Biologics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Biologics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Biologics Market: Breakup by Source (in %), 2020
Figure 5: Global: Biologics Market: Breakup by Product (in %), 2020
Figure 6: Global: Biologics Market: Breakup by Disease (in %), 2020
Figure 7: Global: Biologics Market: Breakup by Manufacturing (in %), 2020
Figure 8: Global: Biologics Market: Breakup by Region (in %), 2020
Figure 9: Global: Biologics (Microbial) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Biologics (Microbial) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Biologics (Mammalian) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Biologics (Mammalian) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Biologics (Other Sources) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Biologics (Other Sources) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Biologics (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Biologics (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Biologics (Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Biologics (Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Biologics (Recombinant Proteins) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Biologics (Recombinant Proteins) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Biologics (Other Products) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Biologics (Other Products) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Biologics (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Biologics (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Biologics (Immunological Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Biologics (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Biologics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Biologics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Biologics (Hematological Disorders) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Biologics (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Biologics (Other Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Biologics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Biologics (Outsourced) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Biologics (Outsourced) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Biologics (In-House) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Biologics (In-House) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: North America: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: North America: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: United States: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: United States: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Canada: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Canada: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Asia-Pacific: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Asia-Pacific: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: China: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: China: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Japan: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Japan: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: India: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: India: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: South Korea: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: South Korea: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Australia: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Australia: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Indonesia: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Indonesia: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Others: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Others: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Europe: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Europe: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Germany: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Germany: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: France: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: France: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: United Kingdom: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: United Kingdom: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Italy: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Italy: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Spain: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Spain: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Russia: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Russia: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Others: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Others: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Latin America: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Latin America: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Brazil: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Brazil: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Mexico: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Mexico: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Others: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Others: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Middle East and Africa: Biologics Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Middle East and Africa: Biologics Market: Breakup by Country (in %), 2020
Figure 87: Middle East and Africa: Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 88: Global: Biologics Industry: SWOT Analysis
Figure 89: Global: Biologics Industry: Value Chain Analysis
Figure 90: Global: Biologics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biologics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Biologics Market Forecast: Breakup by Source (in Million US$), 2021-2026
Table 3: Global: Biologics Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 4: Global: Biologics Market Forecast: Breakup by Disease (in Million US$), 2021-2026
Table 5: Global: Biologics Market Forecast: Breakup by Manufacturing (in Million US$), 2021-2026
Table 6: Global: Biologics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Biologics Market: Competitive Structure
Table 8: Global: Biologics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links